SEARCH

SEARCH BY CITATION

References

  • 1
    Yang IA, Savarimuthu S, Kim ST, Holloway JW, Bell SC, Fong KM. Gene-environmental interaction in asthma. Curr Opin Allergy Clin Immunol 2007;7:7582.
  • 2
    Samuelsson B. An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes. Drugs 1987;33(Suppl. 1):29.
  • 3
    Ogawa Y, Calhoun WJ. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 2006;118:789798; quiz 799-800.
  • 4
    Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997;387:620624.
  • 5
    Miyahara N, Miyahara S, Takeda K, Gelfand EW. Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol Int 2006;55:9197.
  • 6
    Sampson AP, Castling DP, Green CP, Price JF. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child 1995;73:221225.
  • 7
    Shindo K, Fukumura M, Miyakawa K. Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone. Eur Respir J 1995;8:605610.
  • 8
    Evans DJ, Barnes PJ, Spaethe SM, Van Alstyne EL, Mitchell MI, O’Connor BJ. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma. Thorax 1996;51:11781184.
  • 9
    Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, Westcott JY. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995;152:897905.
  • 10
    Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980;286:264265.
  • 11
    Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992;79:29522959.
  • 12
    Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713719.
  • 13
    Wenzel SE. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 1997;17 (1 Pt 2):3S12S.
  • 14
    Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002;166:13451349.
  • 15
    Islam SA, Thomas SY, Hess C, Medoff BD, Means TK, Brander C et al. The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 2006;107:444453.
  • 16
    Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004;36:233239.
  • 17
    Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006;38:6874.
  • 18
    Lohmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005;36:731736.
  • 19
    Sayers I, Barton S, Rorke S, Beghe B, Hayward B, Van Eerdewegh P et al. Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax 2003;58:417424.
  • 20
    Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263265.
  • 21
    Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype–phenotype associations. Eur J Hum Genet 2001;9:301306.
  • 22
    Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004;26:6169.
  • 23
    Sayers I, Barton S, Rorke S, Sawyer J, Peng Q, Beghe B et al. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy 2003;33:11031110.
  • 24
    Hao L, Sayers I, Cakebread JA, Barton SJ, Beghe B, Holgate ST et al. The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma. Clin Exp Allergy 2006;36:735741.
  • 25
    Cordell HJ, Barratt BJ, Clayton DG. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol 2004;26:167185.
  • 26
    Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 2006;173:379385.
  • 27
    Wenzel SE. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids 2003;69:145155.
  • 28
    Montuschi P, Martello S, Felli M, Mondino C, Barnes PJ, Chiarotti M. Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children. Respir Res 2005;6:119.
  • 29
    Sayers I, Sampson AP. Genetic regulation of leukotriene production and activity. In: HolgateST, HollowayJW, eds. The hereditary basis of allergic diseases. Basel: Birkauser Verlag, 2002:137166.
  • 30
    Sampson A, Siddiqui S, Cowburn A, Buchanan D, Howarth P, Holgate S et al. Variant LTC4 synthase allele modifies cysteinyl-leukotriene synthesis in eosinophils and predicts clinical response to Zafarlukast. Thorax 2000;55(Suppl. 2):S28S31.
  • 31
    Maznyczka A, Mangino M, Whittaker A, Braund P, Palmer T, Tobin M et al. Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction. Clin Sci (Lond) 2007;112:411416.
  • 32
    Del Mastro RG, Turenne L, Giese H, Kieth TP, Van Eerdewegh P, May KJ et al. Mechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene. BMC Med Genet 2007;8:46.